In 1969, while still a medical student, Dr. O.H. “Bud” Frazier, MD, found himself massaging the heart of a young man, keeping him alive, albeit briefly. This experience fueled his passion for discovering new ways to save more lives through cardiovascular innovation. Dr. Frazier had been working on...
Many heart attacks are caused when a complete blockage of a heart vessel prevents oxygen-rich blood and nutrients from reaching a section of the heart. If blood cannot reach the heart muscle, it will die. Over time, the condition worsens and weakens the heart. Researchers in the Stem Cell Center at...
Historically, women represent less than 25 percent of cardiovascular research subjects, yet heart disease kills more women than men claiming the life of approximately one woman every minute. Due to this historic under-representation in research, less is known about cardiovascular disease in women...
Cardiovascular disease accounts for a quarter of all deaths in the United States each year, more than the next five causes of death combined. Since 1962, Texas Heart® Institute (THI) at CHI St. Luke’s Health–Baylor St. Luke’s Medical Center has been on the frontlines in the battle to end it by...
Dr. Denton Cooley and his team at CHI St. Luke’s Health–Baylor St. Luke’s Medical Center in Houston made history by performing the first successful human heart transplant in the United States. What followed were decades of life-changing advancements in cardiovascular care developed at Texas Heart®...
Parkinson’s disease can be a debilitating condition. The trembling associated with Parkinson’s and other movement disorders can turn daily activities into difficult tasks. Fortunately, there is a treatment option that can significantly reduce trembling and other symptoms of Parkinson’s disease....
CHI St. Luke’s Health–Baylor St. Luke’s Medical Center raised the bar for standard of medical care for patients with epilepsy and partial onset seizures in April 2014 by offering treatment with the FDA approved NeuroPace® RNS® System. The NeuroPace RNS System is a responsive neurostimulation device...
In conjunction with the extensive research at Baylor College of Medicine, the physicians at CHI St. Luke’s Health–Baylor St. Luke’s Medical Center are leading the way in diagnosis and treatment of rare, progressive cerebrovascular conditions like Moyamoya. Moyamoya Disease is a cerebrovascular...
Dr. Daniel Yoshor, chief of neurosurgery service at CHI St. Luke’s Health–Baylor St. Luke’s Medical Center, is leading the team of investigators who are researching the neurophysiology of human visual perception with the help of an NIH grant. The goal of this project, which is taking place locally...
With roughly 10,000 pituitary tumors diagnosed in the United States each year, Dr. Daniel Yoshor, MD, and his team at CHI St. Luke’s Health–Baylor St. Luke’s Medical Center are revolutionizing the treatment of benign pituitary tumors to allow patients to get back to their everyday routine as...
Looking for tips to keep your health on track? Subscribe to our Health-eNotes newsletter for health resources personalized to your interests! You will receive helpful information to enhance your individual health and wellness. Join us as we create healthier communities!